These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28653284)

  • 1. Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.
    Petrelli F; Coinu A; Rosti G; Pedrazzoli P; Barni S
    Med Oncol; 2017 Aug; 34(8):133. PubMed ID: 28653284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
    Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
    Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
    Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
    Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy for relapsed testicular germ cell tumours.
    Chovanec M; Adra N; Abu Zaid M; Abonour R; Einhorn L
    Nat Rev Urol; 2023 Apr; 20(4):217-225. PubMed ID: 36477219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
    González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
    Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012.
    Necchi A; Lo Vullo S; Bregni M; Rosti G; Mariani L; Raggi D; Giannatempo P; Secondino S; Schumacher K; Massard C; Kanfer E; Oechsle K; Laszlo D; Michieli M; Ifrah N; Mercier M; Crysandt M; Wuchter P; Nagler A; Wahlin A; Martino M; Badoglio M; Pedrazzoli P; Lanza F;
    Clin Genitourin Cancer; 2017 Feb; 15(1):163-167. PubMed ID: 27444987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
    De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
    Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
    Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
    Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
    J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
    J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
    Connolly EA; Weickhardt A; Grimison P; Asher R; Heller GZ; Lewin J; Liow E; Toner G; Tung ILY; Tran B; Hill S; Walpole E; McKenzie J; Kuchel A; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley MA; Hamad N; Wong V
    BJU Int; 2022 Jun; 130 Suppl 1():5-16. PubMed ID: 35355402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
    Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
    Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
    Lorch A; Kleinhans A; Kramar A; Kollmannsberger CK; Hartmann JT; Bokemeyer C; Rick O; Beyer J
    J Clin Oncol; 2012 Mar; 30(8):800-5. PubMed ID: 22291076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and stem cell transplantation for advanced testicular cancer.
    Voss MH; Feldman DR; Motzer RJ
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1091-103. PubMed ID: 21806332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
    Vaena DA; Abonour R; Einhorn LH
    J Clin Oncol; 2003 Nov; 21(22):4100-4. PubMed ID: 14615439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.